S&P: Teva faces greatest liability in US antitrust suit

Teva Photo: ASAP Creative Shutterstock
Teva Photo: ASAP Creative Shutterstock

S&P Global is not changing its rating for Teva's debt at present.

International credit rating agency S&P Global believes that the lawsuit filed by 44 US states against Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) and other pharmaceuticals companies alleging price fixing in relation to generic drugs is negative for Teva's debt rating, but at present S&P is not changing the rating itself. S&P rates Teva's debt BB with a negative outlook (considered a "junk bond" rating).

S&P Global analyst Matthew Todd writes that at this stage the size and timing of the financial outcome of the lawsuit are uncertain, and that the lawsuit has no immediate effect on the rating or rating outlook of the companies concerned (besides Teva, Mylan, Novartis and other companies have been named).

Todd sees the amended antitrust complaint as a negative factor for the companies' credit ratings, "because of the increase in the number of drugs referenced in the complaint (around 100, up from only a few previously) and the more explicit references to evidence, including emails, text messages, phone call records, and unidentified witnesses.

"Although we generally view allegations of collusion and racketeering as difficult to prove," he adds, "we believe the states' case against these companies has strengthened, which increases the likelihood of a significant settlement."

On Teva in particular, Todd writes: "Teva is at the center of the complaint, we suspect the company could face the greatest potential liability. Our long-term issuer credit rating on Teva is contingent on its continued debt repayment over the next two years. Therefore, a significant near-term cash outflow and/or a multi-billion dollar litigation liability, which we view as unlikely at this time, could pressure our rating on the company."

Also last week, HSBC commented on the scale of this affair, and cut its share price target for Teva to $10 from $13, on the basis of the assumption that Teva will have to pay about $3 billion to settle the US lawsuit.

Published by Globes, Israel business news - en.globes.co.il - on May 19, 2019

© Copyright of Globes Publisher Itonut (1983) Ltd. 2019

Teva Photo: ASAP Creative Shutterstock
Teva Photo: ASAP Creative Shutterstock
Inflation  credit: Tali Bogdanovsky Unexpectedly low February CPI reading cuts inflation

While inflation in Israel in the 12 months to the end of February 2025 is lower than forecast, housing prices continue to rise.

Yitzhak Tshuva credit: Gidon Levy and Tali Bogdanovsky Competition Authority allows Delek takeover of Isracard

The Competition Authority is considered the easier of the two regulatory hurdles that the deal must overcome, the other being the Supervisor of Banks.

David Amsalem  credit  Noam Moskowitz, Knesset Spokesperson's Office Rafael to pay state NIS 444m dividend

The minister in charge of the Government Companies Authority, David Amsalem, has approved the payment by the defense company.

Barak MX air defense system  credit: IAI IAI profit jumps 55%

Israel Aerospace Industries posted a net profit of $493 million for 2024, and ended the year with an all-time high orders backlog of $25 billion.

A TSG system in tactical use  credit: PR TSG signs cooperation agreement with US defense co

The agreement includes the integration of TSG's advanced technologies into sensor-based defense systems, which will be integrated into the operational systems of US defense units.

Bria CEO Yair Adato credit: Kseniia Poliak Israeli visual generative AI co Bria raises $40m

Bria’s Visual Generative AI platform empowers businesses to create predictable, controllable, and on-brand content that aligns with their visual language.

Amnon Shashua and Aviram Ziv credit: Eyal Izhar OrCam stymied by investor dispute with Shashua

Demands by institutional investors are blocking the visual and hearing impairment device developer's recovery plan.

Work on the Green Line credit: Bar Lavi Egged wins tender to operate TA light rail Purple, Green Lines

NTA awarded the tender to Egged, which already operates the Red Line, despite government ministry opposition to one operator for the entire network.

Gabi Seroussi illustration: Gil Gibli Board chooses Seroussi as IAI chair as Erdan freezes candidacy

Israel Aerospace Industries board chose Gabi Seroussi as chair even though he did not to go through the preliminary process of the Government Companies Authority appointments review committee.

Bavli Park penthouse credit: Eyal Tagar Tel Aviv Park Bavli penthouse sells for NIS 43m

A 44th floor penthouse in one of the two towers in businessman Yitzhak Tshuva's Park Bavli project has been bought by an Israeli businessperson.

El Al aircraft  credit: Yoav Yaari El Al pilots receive nearly NIS 250,000 bonus each

Thanks to the agreements signed with the unions in 2018, El Al's employees as well as senior management share in last year's success.

Pentera CEO Amitai Ratzon credit: Eyal Izhar Israeli security validation co Pentera raises $60m

Pentera's platform enables security teams to analyze complete attack paths, identify root causes, and prioritize remediation for effective risk reduction.

Tel Aviv credit: Shutterstock Supply of unsold new homes hits record

Israel's real estate market is sliding into recession with 78,000 unsold new apartments in January, the Central Bureau of Statistics reports.

D&B chairman Doron Cohen and Meitar partner Dan Geva Meitar reclaims title of Israel's biggest law firm

Meitar has first place with 537 lawyers, followed by Herzog Fox Neeman with 512 lawyers, according to the latest Dun's 100 rankings.

First International Bank of Israel CEO Eli Cohen  credit: Eyal Toueg First Int'l posts top return on equity

First International Bank of Israel's return on equity in 2024 was 19%, the highest among Israel's banks.

Dina Ben Tal Ganancia  credit: Guy Kushi & Yariv Fein El Al almost quintuples profit

The airline posted a net profit of $545 million for 2024, 4.7 times the profit in 2023, and an all-time high.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018